muraglitazar has been researched along with naveglitazar in 1 studies
| Studies (muraglitazar) | Trials (muraglitazar) | Recent Studies (post-2010) (muraglitazar) | Studies (naveglitazar) | Trials (naveglitazar) | Recent Studies (post-2010) (naveglitazar) |
|---|---|---|---|---|---|
| 85 | 10 | 25 | 7 | 0 | 2 |
| Protein | Taxonomy | muraglitazar (IC50) | naveglitazar (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | 1.916 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.034 | |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | 1.916 | |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | 1.916 | |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | 1.916 | |
| Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | 1.9151 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 2.7106 | |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | 1.916 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kagechika, K; Kubo, H; Shibata, Y; Usui, H; Yamaguchi, M | 1 |
1 other study(ies) available for muraglitazar and naveglitazar
| Article | Year |
|---|---|
Design, synthesis and evaluation of novel zwitterionic compounds as PPARα/γ dual agonists (1).
Topics: Animals; Blood Glucose; Drug Design; Mice; PPAR alpha; PPAR gamma; Structure-Activity Relationship; Thiazolidinediones; Triglycerides; Weight Gain | 2012 |